| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.09 | 0.009 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.009 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |